Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Arthritis & Rheumatism

• Publication date

  2002-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.10173PMID 11920418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The in vivo effects of tumour necrosis factor blockade on the early cell mediated immune events and syndrome expression in rat adjuvant arthritis

  2002cited by this paper
• Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: Interleukin‐17 expression is upregulated in early disease

  2001cited by this paper
• IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

  2001cited by this paper
• The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.

  2001cited by this paper
• Effect of interleukin 17 on proteoglycan degradation in murine knee joints

  2000cited by this paper
• High Levels of IL-17 in Rheumatoid Arthritis Patients: IL-15 Triggers In Vitro IL-17 Production Via Cyclosporin A-Sensitive Mechanism1

  2000cited by this paper
• Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis.

  2000cited by this paper
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

  1999cited by this paper
• Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.

  1999cited by this paper
• Interleukin‐17: A New Bone Acting Cytokine In Vitro

  1999cited by this paper
• Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.

  1999cited by this paper
• Involvement of substance P in the anti‐inflammatory effects of the peripherally selective κ‐opioid asimadoline and the NK1 antagonist GR205171

  1999cited by this paper
• T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

  1996cited by this paper
• Human IL-17: a novel cytokine derived from T cells.

  1995cited by this paper

• Recent developments in the management of Rheumatoid arthritis

  2024cites this paper
• Increased vesicular dynamics and nanoscale clustering of IL-2 after T cell activation.

  2024cites this paper
• Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment

  2023cites this paper
• Drug Repositioning of Metformin Encapsulated in PLGA Combined with Photothermal Therapy Ameliorates Rheumatoid Arthritis

  2023cites this paper
• Single-cell computational machine learning approaches to immune-mediated inflammatory disease: New tools uncover novel fibroblast and macrophage interactions driving pathogenesis

  2023cites this paper
• RORγt inhibition ameliorates IL-23 driven experimental Psoriatic Arthritis by predominantly modulating γδ-T cells.

  2023cites this paper
• The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?

  2023cites this paper
• A review of Janus kinase/signal transducer and activator of transcription signaling and cytokines in the pain mechanism of rheumatoid arthritis

  2023cites this paper
• Osteoimmunology in periodontitis; a paradigm for Th17/IL-17 inflammatory bone loss.

  2022cites this paper
• A Role of IL-17 in Rheumatoid Arthritis Patients Complicated With Atherosclerosis

  2022cites this paper
• No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors

  2022cites this paper
• Lymph node fibroblastic reticular cells regulate differentiation and function of CD4 T cells via CD25

  2022cites this paper
• Interleukin-17A Interweaves the Skeletal and Immune Systems

  2021influential citation
• Metabolomics combined with network pharmacology to study the mechanism of Shentong Zhuyu decoction in the treatment of rheumatoid arthritis.

  2021cites this paper
• Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

  2021cites this paper
• Immunomodulatory Effects of Curcumin in Rheumatoid Arthritis: Evidence from Molecular Mechanisms to Clinical Outcomes.

  2021cites this paper
• Special Issue: "Inflammation and Pathophysiology of COVID-19"

  2020cites this paper
• Increased plasticity of non-classic Th1 cells toward the Th17 phenotype

  2020cites this paper
• Short-Term Efficacy and Safety of Secukinumab for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of RCTs

  2020cites this paper
• Altered T cell plasticity favours Th17 cells in early arthritis.

  2020cites this paper
• Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management

  2020cites this paper
• Interleukin-17 in rheumatoid arthritis: Trials and tribulations

  2020cites this paper
• Anti-inflammatory Property of AMP-activated Protein Kinase

  2020cites this paper
• Dioscin, a Steroidal Saponin Isolated from Dioscorea nipponica, Attenuates Collagen-Induced Arthritis by Inhibiting Th17 Cell Response.

  2019cites this paper
• Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based study.

  2019cites this paper
• IL-38: A New Player in Inflammatory Autoimmune Disorders

  2019influential citation
• Roles of Effector T Cells in Neurological Autoimmunity

  2019cites this paper
• Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials

  2019cites this paper
• Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases

  2019cites this paper
• Immunomodulatory Effects of CP-25 on Splenic T Cells of Rats with Adjuvant Arthritis

  2018cites this paper
• Association between interleukin-17 gene polymorphism and rheumatoid arthritis among Egyptians

  2018cites this paper
• Initial effects of inflammation-related cytokines and signaling pathways on the pathogenesis of post-traumatic osteoarthritis

  2018cites this paper
• The role of Th 1 / Th 2 / Th 17 cytokines and antioxidant defense system in mediating the effects of lemon and grapefruit peel hydroethanolic extracts on adjuvant-induced arthritis in rats

  2018influential citation
• Microbiote intestinal et inflammation : prédiction de la réponse aux anti-TNFα dans les maladies inflammatoires chroniques et modulation de la croissance bactérienne in vitro en réponse au TNFα

  2018cites this paper
• Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial

  2018cites this paper
• IL-17 in the immunopathogenesis of spondyloarthritis

  2018cites this paper
• Ras Signaling Inhibitors Attenuate Disease in Adjuvant-Induced Arthritis via Targeting Pathogenic Antigen-Specific Th17-Type Cells

  2017cites this paper
• Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications

  2017cites this paper
• USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

  2017cites this paper
• NOVELCOMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND NFLAMMLATORY DISEASES Inventors: Christel

  2017cites this paper
• A comparative study of early stage arthritis in three experimental rat models

  2017cites this paper
• Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines

  2017cites this paper
• A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

  2017cites this paper
• A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis.

  2017cites this paper
• The role of IL 23 in the treatment of psoriasis

  2017cites this paper
• Th17 cell responses in spondyloarthritis.

  2017cites this paper
• Pathogenetic Concepts of Joint Diseases

  2017cites this paper
• Estudio comparativo de la fase temprana de artritis experimental en 3 modelos de ratas

  2017cites this paper
• Secukinumab: IL-17A inhibition to treat psoriatic arthritis.

  2016cites this paper
• Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials

  2016cites this paper
• The role of IL-17 in vitiligo: A review.

  2016cites this paper
• IL17A and IL17F gene polymorphisms in patients with rheumatoid arthritis

  2016cites this paper
• Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials

  2016cites this paper
• Mediators of inflammation and bone remodeling in rheumatic disease.

  2016cites this paper
• TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression

  2016cites this paper
• The osteoimmunology of alveolar bone loss

  2016cites this paper
• Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials

  2016cites this paper
• Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases

  2015cites this paper
• Role of the Neutrophil Chemorepellent Soluble Dipeptidyl Peptidase IV in Decreasing Inflammation in a Murine Model of Arthritis

  2015cites this paper
• Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis

  2015cites this paper
• Gαq controls rheumatoid arthritis via regulation of Th17 differentiation

  2015cites this paper
• Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.

  2015cites this paper
• Interleukin 17 deficiency and implications in cutaneous and systemic diseases

  2015cites this paper
• Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics

  2015cites this paper
• Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens

  2015cites this paper
• Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats.

  2015cites this paper
• IL-12p40 Homodimer Ameliorates Experimental Autoimmune Arthritis

  2015cites this paper
• Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.

  2014cites this paper
• Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis

  2014cites this paper
• Increased Th17 Cell Frequency and Poor Clinical Outcome in Rheumatoid Arthritis Are Associated With a Genetic Variant in the IL4R Gene, rs1805010

  2014cites this paper
• Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.

  2014cites this paper
• Peran Alpha-S2 kasein Susu Kambing PE Terhadap Perbaikan Morfologi dan Histologi Membran Synovial Tikus Rheumatoid Arthritis

  2014cites this paper
• Immunopathology of inflammatory bowel disease.

  2014cites this paper
• Therapeutic targets for rheumatoid arthritis: Progress and promises

  2014cites this paper
• The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.

  2014cites this paper
• The roles of TL1A and Pno1 in the pathogenesis of rheumatoid arthritis

  2014cites this paper
• Commercial Bovine Proteoglycan Is Highly Arthritogenic and Can Be Used as an Alternative Antigen Source for PGIA Model

  2014cites this paper
• Etude de la réponse immunitaire T au cours de l'artérite à cellules géantes (Maladie de Horton)

  2014cites this paper
• Interleukin-10 Superfamily and Cancer

  2014cites this paper
• The rheumatoid joint

  2014cites this paper
• Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.

  2013cites this paper
• The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.

  2013cites this paper
• Seminars in Arthritis and Rheumatism

  2013cites this paper
• Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications.

  2013cites this paper
• Immune regulation of bone loss by Th17 cells in oestrogen‐deficient osteoporosis

  2013cites this paper
• Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis

  2013cites this paper
• Role of IL-17 in Psoriasis and Psoriatic Arthritis

  2013cites this paper
• Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.

  2013cites this paper
• Efecto del alendronato sobre el perfil de citoquinas y metaloproteinasas 2 y 9 en un modelo múrido de artritis experimental

  2013cites this paper
• IL-22 and IL-17: An Overview

  2013cites this paper
• Critical Role of IL-17 in Experimental Arthritis

  2013cites this paper
• Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential

  2013cites this paper
• T helper 17 cells in airway diseases: from laboratory bench to bedside.

  2013cites this paper
• Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy

  2013cites this paper
• IL-17 in the Rheumatologist's Line of Sight

  2013cites this paper
• Receptor‐Fc and Ligand Traps as High‐Affinity Biological Blockers: Development and Clinical Applications

  2013cites this paper
• Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.

  2013cites this paper
• System-wide approaches to uncover Th2 cell lineage commitment

  2012cites this paper
• Half‐Life Extension by Fusion to the Fc Region

  2012cites this paper
• Current concepts on the immunopathogenesis of inflammatory bowel disease.

  2012cites this paper